Zimmer Biomet Holdings, Inc <ZBH.N>: UBS Assumes Coverage With Buy Vs Sell Rating; Target Price $115 Vs $89
ZBH•Related News
RxSight Inc <RXST.O>: UBS cuts target price to $5.5 from $9
RXST•
Table-Non-competitive bids for U.S. 6-week bills
TLT•
Freightos integrates air cargo booking into FreightSuite AI-native TMS
CRGO•
UPS forecasts flat third-quarter revenue; shares down
UPS•
Centene falls after flagging bigger drop in Medicaid membership
CNC•